Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience Corey J. Hobbs, MD, Stephen.

Slides:

Advertisements

Similar presentations

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Advertisements

Su K. Metcalfe, MD, MPH, Michael T

Diverticulosis and Diverticulitis

Managing Cancer Pain: Basic Principles and Invasive Treatments

Toward a Strategy of Patient-Centered Access to Primary Care

J. Eric Ahlskog, PhD, MD Mayo Clinic Proceedings

Joseph R. Herges, PharmD, BCPS, Lori B. Herges, PharmD, BCPS, Ross A

Evaluation of Proteinuria

Diverticulosis and Diverticulitis

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002 Antonio L Visbal, MD, Brent.

Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J

William L. Lanier, MD Mayo Clinic Proceedings

Perihilar Cholangiocarcinoma

Toward a Strategy of Patient-Centered Access to Primary Care

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,

Epidemiologic Factors, Clinical Presentation, Causes, and Outcomes of Liver Abscess: A 35-Year Olmsted County Study Ayush Sharma, MBBS, Saurabh Mukewar,

The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors Andrea L. Cheville, MD, MSCE,

68-Year-Old Woman With Dyspnea and Chest Pain

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

The Shrinking Lungs Syndrome in Systemic Lupus Erythematosus

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Brent A. Bauer, MD, Peter L. Elkin, MD, Dana Erickson, MD, George G

Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database Alex.

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Sumit Madan, MD, Robert A. Kyle, MD, Philip R. Greipp, MD

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study Siu-Hin Wan, MD, Joshua P. Slusser, BS, David.

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Ivana T. Croghan, PhD, Sean M. Phelan, PhD, David P

A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic.

Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.

Maximum Standardized Uptake Value on FDG-PET Is a Strong Predictor of Overall and Disease-Free Survival for Non–Small-Cell Lung Cancer Patients after.

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer Yingwei.

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Dying in the Intensive Care Unit: A Candle Vigil Using Illustrations

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Metastatic Breast Cancer

Outpatient Dismissal With a Responsible Adult Compared With Structured Solo Dismissal: A Retrospective Case-Control Comparison of Safety Outcomes David.

Magali P. Disdier Moulder, PharmD, PhD, Jenna M

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

60-Year-Old Man With Rash

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Refurbishing Mayo Clinic Proceedings:

Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer Eva M. Bongers, MD, Cornelis.

Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy Naomi E. Verstegen,

Perihilar Cholangiocarcinoma

Osteoporosis Associated With Megestrol Acetate

Nicholas Trakul, MD, PhD, Jeremy P

Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD

Leadership Models in Health Care—A Case for Servant Leadership

Shawn Nishi, MD, Jie Zhou, PhD, Yong-Fang Kuo, PhD, James S

Jamie Newman, MD, MHA, Renee E. Ziemer, BA

Medical Treatment of Overactive Bladder: In Response

Lowering the High Cost of Cancer Drugs—IV

Mantle Cell Involvement of the Spleen

Squamous Cell Carcinoma of the Tongue

Preoperative Smoking Cessation: The Role of the Primary Care Provider

How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis

Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small-

Joseph R. Herges, PharmD, BCPS, Lori B. Herges, PharmD, BCPS, Ross A

Guru Sonpavde, MD, Teresa G. Hayes, MD Mayo Clinic Proceedings

Managing Cancer Pain: Basic Principles and Invasive Treatments

Acute and Chronic Seizures in Patients Older Than 60 Years

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT Shuichi.

Presentation transcript:

Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non–Small Cell Lung Cancer: The Mayo Clinic Experience Corey J. Hobbs, MD, Stephen J. Ko, MD, Nitesh N. Paryani, MD, Joseph M. Accurso, MD, Kenneth R. Olivier, MD, Yolanda I. Garces, MD, Sean S. Park, MD, MS, PhD, Christopher L. Hallemeier, MD, Steven E. Schild, MD, Sujay A. Vora, MD, Jonathan B. Ashman, MD, PhD, William G. Rule, MD, Johnny R. Bowers, BS, Michael G. Heckman, MS, Nancy N. Diehl, MBA, Robert C. Miller, MD Mayo Clinic Proceedings: Innovations, Quality & Outcomes Volume 2, Issue 1, Pages 40-48 (March 2018) DOI: 10.1016/j.mayocpiqo.2017.11.001 Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 Kaplan-Meier curves showing cumulative incidence of recurrence according to maximum standardized uptake values (SUVmax). Patients were divided into 3 groups of SUVmax on the basis of sample tertiles: low SUVmax, <4.3 (n=91), moderate SUVmax, 4.3-8.7 (n=98), and high SUVmax, >8.7 (n=93). Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2018 2, 40-48DOI: (10.1016/j.mayocpiqo.2017.11.001) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 Kaplan-Meier curves showing cumulative incidence of local recurrence according to biologically effective dose (n=271). Patients were divided on the basis of Gy fractions: 48 Gy in 4 fractions (n=148), 50 Gy in 5 fractions (n=56), or 54 Gy in 3 fractions (n=67). Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2018 2, 40-48DOI: (10.1016/j.mayocpiqo.2017.11.001) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions